Carbamazepine Tablet, Extended Release
Product Images NDC 72516-021

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Carbamazepine (NDC 72516-021). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Oryza Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

200 (Carbamazepine 200mg)

Label for Carbamazepine Extended-Release Tablets, USP 200 mg by Oryza Pharmaceuticals Inc. The label states 100 tablets per container and includes storage instructions, manufacturer and labeler contact details, and warning to keep medications out of reach of children. The label also includes an NDC number and a barcode.*

FDA Label Image

400 mg (Carbamazepine 400mg)

Label for Carbamazepine Extended-Release Tablets, USP 400 mg oral tablets from Oryza Pharmaceuticals Inc. The label includes dosing information, storage instructions, manufacturer details (Qingdao BAHEAL Pharmaceutical Co., Ltd., China), and a barcode. The package contains 100 tablets, labeled Rx only.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of carbamazepine showing the molecular arrangement of carbon, nitrogen, and oxygen atoms including the amide functional group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.